Cargando…

Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers

INTRODUCTION: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Shingo, Watanabe, Kenta, Okuda, Yoshio, Urushihara, Misao, Koshikawa, Hiromi, Chiba, Hitoshi, Yahaba, Misuzu, Taniguchi, Toshibumi, Nakada, Taka-aki, Nakajima, Hiroshi, Ishii, Itsuko, Igari, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885303/
https://www.ncbi.nlm.nih.gov/pubmed/35248497
http://dx.doi.org/10.1016/j.jiac.2022.02.020
_version_ 1784660384087539712
author Yamazaki, Shingo
Watanabe, Kenta
Okuda, Yoshio
Urushihara, Misao
Koshikawa, Hiromi
Chiba, Hitoshi
Yahaba, Misuzu
Taniguchi, Toshibumi
Nakada, Taka-aki
Nakajima, Hiroshi
Ishii, Itsuko
Igari, Hidetoshi
author_facet Yamazaki, Shingo
Watanabe, Kenta
Okuda, Yoshio
Urushihara, Misao
Koshikawa, Hiromi
Chiba, Hitoshi
Yahaba, Misuzu
Taniguchi, Toshibumi
Nakada, Taka-aki
Nakajima, Hiroshi
Ishii, Itsuko
Igari, Hidetoshi
author_sort Yamazaki, Shingo
collection PubMed
description INTRODUCTION: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of Comirnaty®️. METHODS: Healthcare workers (HCWs) who were vaccinated with Comirnaty®️ were asked to register for the application software and to report AEs for 14 days after vaccination. AEs were self-reported according to severity. The software was set to output an alert in case of fever. RESULTS: The number of HCWs who received the first dose was 2,551, and 2,406 (94.3%) reported their vaccinations. 2,547 received the second dose, and 2,347 (92.1%) reported their vaccinations. With the first dose, the reporting rate stayed above 83.3% until the final day. On the other hand, that of the second dose decreased rapidly after 6 days. The most frequent symptom was “pain at injection site” (more than 70%). Severe AEs were 6.6% after the second dose, with 0.6% visiting a clinic. Many AEs peaked on the day after administration and disappeared within 1 week. There were few reports of fever. CONCLUSION: Smartphone applications can be used to collect information on AEs after vaccination. Application settings and dissemination are necessary to maintain the reporting rate of HCWs.
format Online
Article
Text
id pubmed-8885303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88853032022-03-01 Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers Yamazaki, Shingo Watanabe, Kenta Okuda, Yoshio Urushihara, Misao Koshikawa, Hiromi Chiba, Hitoshi Yahaba, Misuzu Taniguchi, Toshibumi Nakada, Taka-aki Nakajima, Hiroshi Ishii, Itsuko Igari, Hidetoshi J Infect Chemother Original Article INTRODUCTION: The usefulness of smartphone-based application software as a way to manage adverse events (AEs) after vaccination is well known. The purpose of this study is to clarify the usefulness and precautions of employing a smartphone application for collecting AEs after the administration of Comirnaty®️. METHODS: Healthcare workers (HCWs) who were vaccinated with Comirnaty®️ were asked to register for the application software and to report AEs for 14 days after vaccination. AEs were self-reported according to severity. The software was set to output an alert in case of fever. RESULTS: The number of HCWs who received the first dose was 2,551, and 2,406 (94.3%) reported their vaccinations. 2,547 received the second dose, and 2,347 (92.1%) reported their vaccinations. With the first dose, the reporting rate stayed above 83.3% until the final day. On the other hand, that of the second dose decreased rapidly after 6 days. The most frequent symptom was “pain at injection site” (more than 70%). Severe AEs were 6.6% after the second dose, with 0.6% visiting a clinic. Many AEs peaked on the day after administration and disappeared within 1 week. There were few reports of fever. CONCLUSION: Smartphone applications can be used to collect information on AEs after vaccination. Application settings and dissemination are necessary to maintain the reporting rate of HCWs. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-06 2022-03-01 /pmc/articles/PMC8885303/ /pubmed/35248497 http://dx.doi.org/10.1016/j.jiac.2022.02.020 Text en © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Yamazaki, Shingo
Watanabe, Kenta
Okuda, Yoshio
Urushihara, Misao
Koshikawa, Hiromi
Chiba, Hitoshi
Yahaba, Misuzu
Taniguchi, Toshibumi
Nakada, Taka-aki
Nakajima, Hiroshi
Ishii, Itsuko
Igari, Hidetoshi
Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title_full Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title_fullStr Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title_full_unstemmed Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title_short Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers
title_sort adverse effect investigation using application software after vaccination against sars-cov-2 for healthcare workers
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885303/
https://www.ncbi.nlm.nih.gov/pubmed/35248497
http://dx.doi.org/10.1016/j.jiac.2022.02.020
work_keys_str_mv AT yamazakishingo adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT watanabekenta adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT okudayoshio adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT urushiharamisao adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT koshikawahiromi adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT chibahitoshi adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT yahabamisuzu adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT taniguchitoshibumi adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT nakadatakaaki adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT nakajimahiroshi adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT ishiiitsuko adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers
AT igarihidetoshi adverseeffectinvestigationusingapplicationsoftwareaftervaccinationagainstsarscov2forhealthcareworkers